about
Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies.Emerging drugs for sickle cell anemia.Endothelin receptor antagonists in sickle cell disease: A promising new therapeutic approach.Rheumatoid Arthritis in Sickle-Cell Population: Pathophysiologic Insights, Clinical Evaluation and Management.
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Tissue factor and thrombin in sickle cell anemia
@ast
Tissue factor and thrombin in sickle cell anemia
@en
Tissue factor and thrombin in sickle cell anemia
@nl
type
label
Tissue factor and thrombin in sickle cell anemia
@ast
Tissue factor and thrombin in sickle cell anemia
@en
Tissue factor and thrombin in sickle cell anemia
@nl
prefLabel
Tissue factor and thrombin in sickle cell anemia
@ast
Tissue factor and thrombin in sickle cell anemia
@en
Tissue factor and thrombin in sickle cell anemia
@nl
P2860
P1433
P1476
Tissue factor and thrombin in sickle cell anemia
@en
P2093
Pichika Chantrathammachart
Rafal Pawlinski
P2860
P356
10.1016/J.THROMRES.2012.02.038
P407
P478
129 Suppl 2
P577
2012-05-01T00:00:00Z